Solanum Dulcamara Stem

For diagnostic purposes, the dosage of Solanum Dulcamara Stem extract is not measured in milligrams but rather in concentration and volume.

• Skin Prick Testing: A single drop of the 1:10 or 1:20 w/v (weight/volume) extract is applied to the skin, followed by a puncture through the drop.
• Intradermal Testing: If the prick test is negative, a healthcare provider may administer 0.02 mL to 0.05 mL of a 1:100 or 1:1000 dilution via intradermal injection.
• Therapeutic Use (Homeopathic): Common adult dosing for homeopathic preparations involves 3-5 pellets of a 30C dilution taken three times daily, though this must be directed by a qualified practitioner.

Solanum Dulcamara Stem extract may be used in children for allergy testing under the strict supervision of a pediatric allergist.

• Children (Ages 2-12): Diagnostic skin prick testing follows the same protocol as adults, though the number of simultaneous tests may be limited to prevent excessive discomfort or systemic absorption.
• Infants (Under 2 years): Safety and efficacy for diagnostic testing have not been widely established. Use is generally reserved for cases where the clinical need outweighs the potential risks.
• Caution: Pediatric patients are more susceptible to the toxic effects of glycoalkaloids. Any use of non-diluted Solanum Dulcamara products is strictly contraindicated in children.

Renal Impairment

No specific dosage adjustments are required for diagnostic skin testing, as systemic absorption is minimal. However, in cases of accidental ingestion or systemic therapy, patients with a GFR (Glomerular Filtration Rate) below 30 mL/min should be monitored closely for signs of alkaloid toxicity due to reduced renal clearance.

Hepatic Impairment

Patients with severe hepatic impairment (Child-Pugh Class C) may have a reduced capacity to metabolize the glycoalkaloids found in Solanum Dulcamara. While diagnostic testing is generally safe, systemic exposure should be avoided.

Elderly Patients

Geriatric patients often have thinner skin, which may lead to more pronounced reactions during allergy testing. Healthcare providers may use more dilute concentrations to avoid false-positive results or excessive irritation.

Solanum Dulcamara Stem is almost exclusively administered by a healthcare professional in a clinical setting.

• For Allergy Testing: The skin (usually the forearm or back) is cleaned with alcohol. The extract is applied, and the skin is pricked. The area must remain dry and undisturbed for 15 to 20 minutes until the provider reads the results.
• For Homeopathic Use: If prescribed as an oral pellet, it should be dissolved under the tongue (sublingual). Avoid eating or drinking anything other than water for 15 minutes before and after administration to ensure optimal absorption.
• Storage: Extracts must be stored in a refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze. Keep out of reach of children, as the concentrated extract is toxic if swallowed.

As this substance is primarily used for diagnostic procedures, a missed dose typically refers to a missed appointment. If you are using a homeopathic preparation and miss a dose, take it as soon as you remember. However, if it is nearly time for your next dose, skip the missed dose and resume your regular schedule. Do not double the dose to catch up.

An overdose of Solanum Dulcamara Stem extract is rare when used diagnostically but can occur through accidental ingestion of the plant or concentrated extract.

• Symptoms: Nausea, vomiting, diarrhea, abdominal pain, dizziness, dilated pupils (mydriasis), rapid heart rate (tachycardia), and in severe cases, respiratory depression or hallucinations.
• Emergency Measures: If ingestion is suspected, contact a Poison Control Center immediately. Emergency treatment may include gastric lavage, administration of activated charcoal, and supportive care for respiratory and cardiovascular stability.

> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or use this substance without medical guidance.

When used for diagnostic allergy testing, the most common side effects are localized to the site of administration. These are often expected outcomes of the test rather than adverse events:

• Local Pruritus (Itching): A significant itching sensation at the site of the prick or injection is very common and usually subsides within 30 to 60 minutes.
• Erythema (Redness): The skin surrounding the test site may become red and warm to the touch.
• Wheal Formation: A raised, white or pale bump (similar to a mosquito bite) is the standard positive reaction to the allergen.

• Persistent Irritation: In some patients, the redness and itching may last for 24 to 48 hours.
• Contact Dermatitis: Some individuals may develop a localized rash or small blisters if they have a delayed hypersensitivity to the glycerin or other preservatives in the extract.
• Fatigue: A small number of patients report feeling mildly tired or 'foggy' following extensive allergy testing panels.

• Lymphangitis: Inflammation of the lymph vessels near the test site, appearing as red streaks.
• Vasovagal Response: Fainting or lightheadedness, usually triggered by the needle prick rather than the substance itself.
• Systemic Urticaria: Hives appearing on parts of the body away from the test site.

> Warning: Stop taking Solanum Dulcamara Stem and call your doctor immediately if you experience any of these.

• Anaphylaxis: This is a life-threatening allergic reaction. Symptoms include swelling of the throat or tongue, difficulty breathing, a sudden drop in blood pressure (feeling faint), and a rapid, weak pulse.
• Angioedema: Deep swelling under the skin, particularly around the eyes, lips, or hands.
• Bronchospasm: Sudden constriction of the airways, leading to wheezing and shortness of breath, particularly in patients with pre-existing asthma.
• Solanine Toxicity (Systemic): If absorbed in large quantities, symptoms include confusion, tremors, and cardiac arrhythmias.

Because Solanum Dulcamara Stem is generally used for short-term diagnostic purposes, long-term side effects from medical use are rare. However, chronic exposure to the plant or its extracts (e.g., in occupational settings) may lead to:

• Chronic Eczematous Dermatitis: Persistent skin inflammation and thickening.
• Sensitization: Increased sensitivity not only to Solanum Dulcamara but also to other members of the Solanaceae family (cross-reactivity).

There is no specific FDA black box warning for Solanum Dulcamara Stem as a standalone ingredient. However, all Allergenic Extracts carry a general warning regarding the risk of severe systemic allergic reactions.

Summary of General Warning for Allergenic Extracts:

• These products can cause severe life-threatening systemic reactions, including anaphylaxis.
• They should only be administered by healthcare providers equipped to treat such reactions.
• Patients with unstable asthma are at a higher risk for severe reactions.
• Patients must be observed for at least 30 minutes following administration.

Report any unusual symptoms to your healthcare provider.

Solanum Dulcamara Stem is a potent biological substance. It must only be used under the supervision of a licensed healthcare professional, preferably an allergist or immunologist. Patients should be aware that while the extract is used to diagnose allergies, it is itself an allergen and carries the risk of inducing the very symptoms it is meant to identify.

No FDA black box warnings specifically for Solanum Dulcamara Stem exist; however, as noted in the side effects section, it falls under the class-wide warnings for non-standardized allergenic extracts. This includes the requirement for administration in a facility with emergency resuscitative equipment and a mandatory observation period post-injection.

• Allergic Reactions / Anaphylaxis Risk: The primary risk is a systemic allergic reaction. Patients who are highly sensitive or who are currently experiencing an asthma flare-up are at the highest risk. Always inform your doctor if you have had a previous severe reaction to any plant extract.
• Asthma Status: Patients with severe or poorly controlled asthma should not undergo skin testing with Solanum Dulcamara Stem extract until their asthma is stabilized, as they are at increased risk for severe bronchospasm.
• Beta-Blocker Use: Patients taking beta-blockers (medications for blood pressure or heart conditions) may be resistant to the effects of epinephrine, which is the primary treatment for anaphylaxis. This makes any potential allergic reaction much more dangerous.
• Skin Conditions: Testing should not be performed on skin areas with active eczema, psoriasis, or infection, as this can lead to false results or worsening of the skin condition.

• Immediate Observation: After skin testing, patients must remain in the clinic for at least 30 minutes to be monitored for signs of systemic reactions.
• Lung Function: In patients with a history of asthma, a peak flow or spirometry test may be performed before and after administration to ensure no significant airway obstruction has occurred.
• Site Monitoring: Patients should monitor the test site for the next 24 hours for signs of delayed reactions or infection (increasing pain, pus, or spreading redness).

Solanum Dulcamara Stem generally does not affect the ability to drive or operate machinery. However, if a patient experiences a vasovagal response (fainting) or a systemic reaction requiring medication (like antihistamines that cause drowsiness), they should avoid these activities until they have fully recovered.

There are no direct interactions between alcohol and Solanum Dulcamara Stem extract. However, alcohol can cause vasodilation (widening of blood vessels), which may theoretically increase the rate of absorption of the extract or worsen the itching and redness at the test site.

For diagnostic use, there is no 'discontinuation' process. For homeopathic use, the product can usually be stopped without a tapering period. However, if you are using it for a chronic condition, symptoms may return upon stopping the treatment. Always consult your provider before ending a prescribed course of therapy.

> Important: Discuss all your medical conditions with your healthcare provider before starting Solanum Dulcamara Stem.

There are few absolute contraindications for the diagnostic use of Solanum Dulcamara Stem, but the following should be avoided to ensure safety and accuracy:

• Non-Selective Beta-Blockers (e.g., Propranolol): While not strictly contraindicated, they significantly increase the risk of fatal anaphylaxis because they interfere with the emergency treatment (epinephrine). Many clinicians will postpone testing until the patient can be safely transitioned to another medication.

• Systemic Corticosteroids (e.g., Prednisone): These medications suppress the immune system and can significantly dampen the 'wheal and flare' response, leading to a false-negative result. Patients usually need to be off oral steroids for at least 1-2 weeks before testing.
• Tricyclic Antidepressants (e.g., Amitriptyline): These drugs have potent antihistamine properties and can interfere with skin test results for several days after the last dose.

• Antihistamines (H1 Blockers like Loratadine, Cetirizine, Diphenhydramine): These are the most common cause of inaccurate allergy tests. They must be discontinued 3 to 7 days prior to testing with Solanum Dulcamara Stem extract.
• H2 Blockers (e.g., Famotidine): While less potent than H1 blockers, they can still slightly reduce the skin's reaction to allergens.
• Topical Steroids: If applied directly to the test site, they will inhibit the local inflammatory response.

• Nightshade Vegetables: Consuming large amounts of potatoes, tomatoes, or eggplants may theoretically affect the baseline sensitivity of a patient being tested for Solanum Dulcamara, though this is not clinically standardized.
• High-Fat Meals: If using oral preparations (rare), high-fat meals may increase the absorption of the glycoalkaloids, potentially increasing the risk of side effects.

• St. John's Wort: May affect the hepatic metabolism of the alkaloids found in the stem, though the clinical significance is low for diagnostic use.
• Licorice Root: May have mild corticosteroid-like effects that could interfere with the skin's inflammatory response during testing.

Solanum Dulcamara Stem extract does not typically interfere with standard blood chemistry or hematology tests. However, its use is intended to influence the results of Skin Allergy Tests. It may also cross-react with In Vitro IgE tests (RAST or ImmunoCAP) for other Solanaceae species, leading to a broader positive profile than the patient may actually have clinically.

For each major interaction, the mechanism is usually pharmacodynamic (interfering with the body's response to the drug) rather than pharmacokinetic. The clinical consequence is almost always a false negative test result, which could lead to a failure to diagnose a significant allergy. The management strategy is always to discontinue the interfering medication for an appropriate washout period before testing.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking.

Solanum Dulcamara Stem must NEVER be used in the following circumstances:

• Previous Anaphylaxis to Solanum Species: If a patient has a documented history of life-threatening reactions to bittersweet nightshade or closely related plants, even diagnostic testing is considered too high-risk.
• Severe, Uncontrolled Asthma: Patients with a Forced Expiratory Volume (FEV1) of less than 70% of predicted values are at an unacceptably high risk for a fatal respiratory reaction during testing.
• Acute Infection or Fever: Testing during an active illness can lead to unpredictable immune responses and systemic complications.
• Recent Myocardial Infarction (Heart Attack): The stress of a potential systemic reaction and the potential need for epinephrine (which stresses the heart) makes testing contraindicated within 3-6 months of a major cardiac event.

These conditions require a careful risk-benefit analysis by the physician:

• Pregnancy: While not directly toxic in diagnostic doses, the risk of inducing a systemic reaction that could cause fetal distress is a major concern.
• Dermatographism: A condition where the skin becomes raised and red with even minor stroking. This makes interpreting a 'positive' allergy test nearly impossible.
• Beta-Blocker Therapy: As mentioned, this complicates the treatment of potential anaphylaxis.

Patients who are allergic to Solanum Dulcamara Stem may also react to:

• Other Solanum species: Including Solanum tuberosum (Potato) and Solanum lycopersicum (Tomato).
• Other Nightshades: Including Belladonna (Atropa belladonna) and Stramonium (Datura stramonium).
• Latex: Some studies suggest a cross-reactivity between certain plant alkaloids/proteins and latex (Latex-Fruit Syndrome).

> Important: Your healthcare provider will evaluate your complete medical history before prescribing Solanum Dulcamara Stem.

Solanum Dulcamara Stem is classified as Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women. Animal studies have shown that glycoalkaloids like solanine can be teratogenic (causing birth defects), particularly neural tube defects, when consumed in high doses.

• Diagnostic Risk: The primary risk during pregnancy is not the substance itself but the potential for an anaphylactic reaction, which can cause maternal hypoxia (low oxygen) and subsequent fetal distress or miscarriage.
• Recommendation: Allergy testing with Solanum Dulcamara Stem is generally postponed until after delivery unless the diagnosis is critical for managing severe maternal health issues.

It is not known whether the constituents of Solanum Dulcamara Stem extract are excreted in human milk. Because many alkaloids are lipophilic and can pass into milk, caution is advised. However, the tiny amount used in a diagnostic skin test is unlikely to result in measurable levels in breast milk. Systemic or homeopathic use should be discussed with a lactation consultant.

Safety and effectiveness in children under the age of 2 have not been established. In older children, the extract is used for diagnostic purposes, but the 'wheal' response may be smaller than in adults, requiring expert interpretation. Children are more sensitive to the toxic effects of the Solanaceae family; therefore, any accidental ingestion of the plant or extract is a pediatric emergency.

Clinical studies of Solanum Dulcamara Stem extract did not include sufficient numbers of subjects aged 65 and over to determine if they respond differently than younger subjects. In general, elderly patients have a higher prevalence of cardiovascular disease and may be taking medications (like beta-blockers or ACE inhibitors) that increase the risk of complications from allergy testing. Renal function should be considered if any systemic absorption is anticipated.

Since the alkaloids in Solanum Dulcamara are primarily excreted by the kidneys, patients with pre-existing renal disease (Stage 3 or higher) should be monitored for signs of toxicity if they are exposed to systemic levels of the substance. For diagnostic skin testing, no dose adjustment is needed, but the patient's overall health status must be stable.

The liver is responsible for the detoxification of glycoalkaloids. Patients with cirrhosis or acute hepatitis may have a reduced ability to process these compounds. While skin testing is generally safe, these patients should avoid any oral or systemic botanical preparations containing Solanum Dulcamara.

> Important: Special populations require individualized medical assessment.

Solanum Dulcamara Stem works through two distinct pathways depending on the context of use:

1. 1Immunological: It acts as an antigen. Upon contact with the dermal layer, the proteins in the extract cross-link IgE antibodies on mast cells and basophils. This triggers the release of pre-formed mediators (histamine) and the synthesis of new mediators (leukotrienes), resulting in a localized inflammatory response.
2. 2Toxicological/Pharmacological: The glycoalkaloids (solanine, solasodine) act as acetylcholinesterase inhibitors. By inhibiting this enzyme, they cause an accumulation of acetylcholine at nerve synapses, which can lead to cholinergic symptoms. Additionally, these compounds can disrupt cell membranes by binding to sterols, which explains the gastrointestinal irritation seen in toxicity.

In diagnostic testing, the onset of action is rapid (15-20 minutes). The duration of the localized 'wheal' is typically 2-6 hours. There is a clear dose-response relationship; higher concentrations of the extract produce larger wheals in sensitive individuals. Tolerance does not typically develop with diagnostic use, but repeated exposure in immunotherapy can lead to desensitization (IgG4-mediated).

| Parameter | Value |

|---|---|

| Bioavailability | <5% (Oral); Negligible (Dermal) |

| Protein Binding | ~40-60% (Solanine) |

| Half-life | 10-20 hours |

| Tmax | 2-4 hours (if ingested) |

| Metabolism | Hepatic (Hydrolysis to aglycones) |

| Excretion | Renal 70%, Fecal 30% |

The stem contains several key chemical constituents:

• Molecular Formula (Solanine): C45H73NO15
• Molecular Weight: 868.06 g/mol
• Solubility: Soluble in dilute acids; poorly soluble in water at neutral pH.
• Structure: A trisaccharide (solatetraose) linked to a steroidal alkaloid (solanidine).

Solanum Dulcamara Stem is classified as a Non-Standardized Plant Allergenic Extract. It shares this class with other botanical extracts like Poison Ivy (Toxicodendron) and various grass pollens. It is distinct from 'Standardized Extracts' (like Ragweed or Dust Mite), which have federally defined units of potency (e.g., BAU/mL).